CRYO-CELL INTERNATIONAL, INC. Long-Term Debt, Maturity, Year Four
CRYO-CELL INTERNATIONAL, INC. (CCEL) had Long-Term Debt, Maturity, Year Four of $249.65 thousand as of 2026-05-31, per its 10-Q filed 2026-07-15.
Financial Statements › Notes › Commitment and Contingencies › Long-Term Debt, Fiscal Year Maturity › Long-Term Debt, Maturity, Year Four and Five
us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour · last filed 2026-07-15
- 2026-05-31: Long-Term Debt, Maturity, Year Four $249.65K.
- 2026-02-28: Long-Term Debt, Maturity, Year Four $245.83K.
- 2025-11-30: Long-Term Debt, Maturity, Year Four $227.44K.
- 2025-05-31: Long-Term Debt, Maturity, Year Four $234.61K.
| Period end | Long-Term Debt, Maturity, Year Four |
|---|---|
| 2026-05-31 | $249.65K 10-Q · filed 2026-07-15 |
| 2026-02-28 | $245.83K 10-Q · filed 2026-04-14 |
| 2025-11-30 | $227.44K 10-K · filed 2026-02-27 |
| 2025-05-31 | $234.61K 10-Q · filed 2025-07-15 |
| 2025-02-28 | $231.02K 10-Q · filed 2025-04-14 |
| 2024-11-30 | $201.99K 10-K · filed 2025-02-28 |
| 2018-11-30 | $3.10M 10-K · filed 2019-02-28 |
| 2017-11-30 | $1.50M 10-K · filed 2018-02-28 |
| 2016-11-30 | $2.00M 10-K · filed 2017-02-28 |
| 2015-11-30 | $206.12K 10-K · filed 2016-02-29 |
| 2015-08-31 | $339.68K 10-Q · filed 2015-10-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |